Send to:

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2005 Apr 1;40 Suppl 4:S240-5.

Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification.

Author information

  • 1Infectious Disease Unit, University of Genova/National Institute for Cancer Research, 16132 Genova, Italy.


Determinations of the type and setting of empirical therapy for immunocompromised patients with fever are complicated by the characteristics of the underlying illness and the effects of treatments already received, as well as by changing microbiological patterns and trends in drug resistance at national and institutional levels. Several systems have been proposed to distinguish patients who could benefit from outpatient antibiotic therapy from patients who require hospitalization. Practical considerations may decide whether the necessary monitoring during the period of neutropenia can be achieved.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk